RxSight

RXST72

High Growth

$46.38arrow_drop_up3.55%$1.59

High Growth

RXST72

$46.38

arrow_drop_up3.55%$1.59

High Growth

Performance History

Key Stats
Open	$45.30
Prev. Close	$44.83
EPS	-0.81
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	44.83	47.63
52 Week Range	20.66	66.54

Ratios







EPS	-0.81

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About RxSight (RXST)

RxSight, Inc. (RXST) is a company that specializes in advanced vision correction solutions. The company's stock price history has shown steady growth over the years, reflecting the success and potential of its innovative technologies. Since its initial public offering, RXST has consistently demonstrated strong performance in the market.

As a leader in the field, RxSight is committed to providing the highest quality products and services to its customers. The company's dedication to innovation and research has led to breakthrough advancements in vision correction, revolutionizing the way people see the world. With its cutting-edge technology, RxSight offers customizable lenses that can be adjusted after cataract surgery, allowing patients to achieve optimal visual outcomes.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Dr. Ronald M. Kurtz M.D.
Headquarters: Aliso Viejo
Employees: 292
Exchange: NASDAQ

Keep an eye on RxSight

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is RxSight's (RXST) price per share?

The current price per share for RxSight (RXST) is $46.38. The stock has seen a price change of $1.59 recently, indicating a 3.56% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for RxSight (RXST)?

For RxSight (RXST), the 52-week high is $66.54, which is 43.47% from the current price. The 52-week low is $20.66, the current price is 124.49% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is RxSight (RXST) a growth stock?

RxSight (RXST) has shown an average price growth of -3.36% over the past three years. It has received a score of 89 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying RxSight as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is RxSight (RXST) stock price performance year to date (YTD)?

As of the latest data, RxSight (RXST) has a year-to-date price change of 26.55%. Over the past month, the stock has experienced a price change of -6.44%. Over the last three months, the change has been -16.97%. Over the past six months, the figure is -24.15%.

help

Is RxSight (RXST) a profitable company?

RxSight (RXST) has a net income of -$48.61M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 60.36% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -26.13% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $89.08M, with a revenue growth rate of 81.77%, providing insight into the company's sales performance and growth. The gross profit is $53.76M. Operating income is noted at -$50.08M. Furthermore, the EBITDA is -$34.97M.

help

What is the market capitalization of RxSight (RXST)?

RxSight (RXST) has a market capitalization of $1.87B. The average daily trading volume is 46, indicating the stock's liquidity and investor engagement.